These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 10767570)

  • 1. Advancing liposome technology for innovative strategies against malaria.
    Miatmoko A; Octavia RT; Araki T; Annoura T; Sari R
    Saudi Pharm J; 2024 Jun; 32(6):102085. PubMed ID: 38690211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis.
    Wang W; Joyce P; Bremmell K; Milne R; Prestidge CA
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes for malaria management: the evolution from 1980 to 2020.
    Memvanga PB; Nkanga CI
    Malar J; 2021 Jul; 20(1):327. PubMed ID: 34315484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes.
    Miatmoko A; Nurjannah I; Nehru NF; Rosita N; Hendradi E; Sari R; Ekowati J
    Sci Rep; 2021 Jun; 11(1):12420. PubMed ID: 34127730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile.
    Mukthavaram R; Jiang P; Saklecha R; Simberg D; Bharati IS; Nomura N; Chao Y; Pastorino S; Pingle SC; Fogal V; Wrasidlo W; Makale M; Kesari S
    Int J Nanomedicine; 2013; 8():3991-4006. PubMed ID: 24174874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.
    Bertol CD; Oliveira PR; Kuminek G; Rauber GS; Stulzer HK; Silva MA
    Ann Trop Med Parasitol; 2011 Oct; 105(7):475-84. PubMed ID: 22185941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-property relationship modeling of remote liposome loading of drugs.
    Cern A; Golbraikh A; Sedykh A; Tropsha A; Barenholz Y; Goldblum A
    J Control Release; 2012 Jun; 160(2):147-57. PubMed ID: 22154932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of pharmaceuticals to oxidative degradation.
    Waterman KC; Adami RC; Alsante KM; Hong J; Landis MS; Lombardo F; Roberts CJ
    Pharm Dev Technol; 2002 Jan; 7(1):1-32. PubMed ID: 11852692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design.
    Stensrud G; Sande SA; Kristensen S; Smistad G
    Int J Pharm; 2000 Apr; 198(2):213-28. PubMed ID: 10767570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
    Qiu L; Jing N; Jin Y
    Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and characterization of boanmycin-loaded liposomes prepared by pH gradient experimental design.
    Liu Y; Yoo SD; Li L; Fang L; Wen Z; Li T
    Drug Deliv; 2012 Feb; 19(2):90-101. PubMed ID: 22283679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes.
    Arica B; Ozer AY; Ercan MT; Hincal AA
    J Microencapsul; 1995; 12(5):469-85. PubMed ID: 8544091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyzine- and cetirizine-loaded liposomes: effect of duration of thin film hydration, freeze-thawing, and changing buffer pH on encapsulation and stability.
    Elzainy AA; Gu X; Simons FE; Simons KJ
    Drug Dev Ind Pharm; 2005 Mar; 31(3):281-91. PubMed ID: 15830724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pH, ionic strength and oxygen burden on the chemical stability of EPC/cholesterol liposomes under accelerated conditions. Part 1: Lipid hydrolysis.
    Zhang JA; Pawelchak J
    Eur J Pharm Biopharm; 2000 Nov; 50(3):357-64. PubMed ID: 11072192
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.